| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,594 |
2,304 |
$327K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,990 |
4,235 |
$191K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
727 |
549 |
$141K |
| A0425 |
Ground mileage, per statute mile |
587 |
473 |
$46K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,852 |
1,257 |
$38K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
399 |
396 |
$28K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
720 |
628 |
$25K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
108 |
90 |
$16K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
345 |
314 |
$16K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
332 |
232 |
$15K |
| 59430 |
|
116 |
107 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
334 |
163 |
$9K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
159 |
144 |
$8K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
159 |
144 |
$8K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
72 |
69 |
$7K |
| 81002 |
|
2,268 |
1,432 |
$6K |
| 80050 |
General health panel |
40 |
38 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
2,920 |
2,500 |
$4K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
103 |
92 |
$4K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
137 |
76 |
$3K |
| 80053 |
Comprehensive metabolic panel |
555 |
469 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
305 |
274 |
$3K |
| 80081 |
|
27 |
24 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
12 |
12 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
880 |
716 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
166 |
159 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
12 |
12 |
$1K |
| 81001 |
|
545 |
489 |
$1K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
42 |
42 |
$1K |
| 87653 |
|
25 |
25 |
$1K |
| 90686 |
|
56 |
55 |
$842.89 |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
17 |
16 |
$831.96 |
| 84443 |
Thyroid stimulating hormone (TSH) |
51 |
48 |
$772.06 |
| G0378 |
Hospital observation service, per hour |
15 |
13 |
$718.35 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
28 |
27 |
$534.61 |
| 59025 |
Fetal non-stress test |
20 |
16 |
$517.83 |
| 80306 |
|
15 |
13 |
$436.42 |
| 11721 |
|
49 |
45 |
$379.02 |
| 90656 |
|
17 |
17 |
$244.58 |
| 86803 |
|
13 |
12 |
$234.97 |
| 87081 |
|
25 |
25 |
$177.09 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12 |
12 |
$162.01 |
| 87210 |
|
27 |
24 |
$161.12 |
| 82950 |
|
28 |
25 |
$152.57 |
| 84030 |
|
12 |
12 |
$90.36 |
| 11719 |
|
14 |
13 |
$11.76 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
340 |
232 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
60 |
45 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
15 |
14 |
$0.00 |
| 99457 |
|
61 |
61 |
$0.00 |
| 1036F |
|
385 |
281 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
467 |
392 |
$0.00 |
| 99458 |
|
12 |
12 |
$0.00 |